119th Congress · House bill · Last action Jun 24, 2025
H.R. 1082Passed HouseHealth
Shandra Eisenga Human Cell and Tissue Product Safety Act
Sponsor: Rep. Moolenaar, John R. (R-MI)1 cosponsorIntroduced Feb 6, 2025
✆
In plain English
A plain-English summary isn’t available for this bill yet.
Where it is in the process
✓
Introduced
Feb 6
✓
House committee
Apr 29
✓
House floor
Jun 23
4
Senate
-
5
Signed
-
What happens next: Cleared the House. Now goes to the Senate for consideration.
Community vote
How readers of ThePolitibase feel about this bill. Reader sentiment only — not a scientific poll, and not a measure of public opinion.
- support · - oppose · - total
District map
Scroll or use + / − to zoom, drag to pan. Search a ZIP or district to jump there.
Hover a district to see the member and how they voted.
Add your voice
Reader sentiment only — not a scientific poll, one vote per network. Find your district above (by ZIP or code), then weigh in.
No district selected
Sponsor
JR
Cosponsors (1)
DR
All Democratic.
Activity timeline
Jun 24
Jun 24, 2025
Jun 24, 2025
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 23
Jun 23, 2025
Jun 23, 2025
Motion to reconsider laid on the table Agreed to without objection.
Jun 23
Jun 23, 2025
Jun 23, 2025
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
Jun 23
Jun 23, 2025
Jun 23, 2025
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
Jun 23
Jun 23, 2025
Jun 23, 2025
DEBATE - The House proceeded with forty minutes of debate on H.R. 1082.
Jun 23
Jun 23, 2025
Jun 23, 2025
Considered under suspension of the rules. (consideration: CR H2860-2862)
Jun 23
Jun 23, 2025
Jun 23, 2025
Mr. Bilirakis moved to suspend the rules and pass the bill.
Jun 12
Jun 12, 2025
Jun 12, 2025
Placed on the Union Calendar, Calendar No. 127.
Jun 12
Jun 12, 2025
Jun 12, 2025
Reported by the Committee on Energy and Commerce. H. Rept. 119-160.
Jun 12
Jun 12, 2025
Jun 12, 2025
Reported by the Committee on Energy and Commerce. H. Rept. 119-160.
Read the bill text
Official text via Congress.gov. Opens in a new tab.
Full action log
All 15 recorded actions since introduction · Source: Congress.gov
Jun 24
SENATEReceived in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 23
HOUSEMotion to reconsider laid on the table Agreed to without objection.
Jun 23
HOUSEOn motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
Jun 23
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
Jun 23
HOUSEDEBATE - The House proceeded with forty minutes of debate on H.R. 1082.
Jun 23
HOUSEConsidered under suspension of the rules. (consideration: CR H2860-2862)
Jun 23
HOUSEMr. Bilirakis moved to suspend the rules and pass the bill.
Jun 12
HOUSEPlaced on the Union Calendar, Calendar No. 127.
Jun 12
HOUSEReported by the Committee on Energy and Commerce. H. Rept. 119-160.
Jun 12
Reported by the Committee on Energy and Commerce. H. Rept. 119-160.
Apr 29
HOUSEOrdered to be Reported by Voice Vote.
Apr 29
HOUSECommittee Consideration and Mark-up Session Held
Feb 6
HOUSEReferred to the House Committee on Energy and Commerce.
Feb 6
Introduced in House
Feb 6
Introduced in House
All 1 cosponsor
1 Democrat · 0 Republicans
Democrats (1)
Dingell, DebbieMI-06
In the news
Track this bill
Get an alert when it moves to the next stage or gets a vote.